Global Oral Proteins and Peptides Sales Market Report 2021

Publisher Name :
Date: 26-May-2021
No. of pages: 129
Inquire Before Buying

The global Oral Proteins and Peptides market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Proteins and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Linaclotide

- Calcitonin

- Insulin

- Octreotide

Segment by Application

- Gastric & Digestive Disorders

- Bone Diseases

- Diabetes

- Hormonal Disorders

The Oral Proteins and Peptides market is analysed and market size information is provided by regions (countries). Segment by Application, the Oral Proteins and Peptides market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Allergan

- AstraZeneca

- Biocon

- Generex Biotechnology

- Novo Nordisk

- Synergy Pharmaceuticals

- Tarsa Therapeutics

- Sanofi

- Hoffmann-La Roche

- Synthetic Biologics

- Hovione

- Novartis

Global Oral Proteins and Peptides Sales Market Report 2021

Table of Contents
1 Oral Proteins and Peptides Market Overview
1.1 Oral Proteins and Peptides Product Scope
1.2 Oral Proteins and Peptides Segment by Type
1.2.1 Global Oral Proteins and Peptides Sales by Type (2016 & 2021 & 2027)
1.2.2 Linaclotide
1.2.3 Calcitonin
1.2.4 Insulin
1.2.5 Octreotide
1.3 Oral Proteins and Peptides Segment by Application
1.3.1 Global Oral Proteins and Peptides Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Gastric & Digestive Disorders
1.3.3 Bone Diseases
1.3.4 Diabetes
1.3.5 Hormonal Disorders
1.4 Oral Proteins and Peptides Market Estimates and Forecasts (2016-2027)
1.4.1 Global Oral Proteins and Peptides Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Oral Proteins and Peptides Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Oral Proteins and Peptides Price Trends (2016-2027)
2 Oral Proteins and Peptides Estimates and Forecasts by Region
2.1 Global Oral Proteins and Peptides Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Oral Proteins and Peptides Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Oral Proteins and Peptides Sales Market Share by Region (2016-2021)
2.2.2 Global Oral Proteins and Peptides Revenue Market Share by Region (2016-2021)
2.3 Global Oral Proteins and Peptides Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Oral Proteins and Peptides Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Oral Proteins and Peptides Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Oral Proteins and Peptides Estimates and Projections (2016-2027)
2.4.2 Europe Oral Proteins and Peptides Estimates and Projections (2016-2027)
2.4.3 China Oral Proteins and Peptides Estimates and Projections (2016-2027)
2.4.4 Japan Oral Proteins and Peptides Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Oral Proteins and Peptides Estimates and Projections (2016-2027)
2.4.6 India Oral Proteins and Peptides Estimates and Projections (2016-2027)
3 Global Oral Proteins and Peptides Competition Landscape by Players
3.1 Global Top Oral Proteins and Peptides Players by Sales (2016-2021)
3.2 Global Top Oral Proteins and Peptides Players by Revenue (2016-2021)
3.3 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Proteins and Peptides as of 2020)
3.4 Global Oral Proteins and Peptides Average Price by Company (2016-2021)
3.5 Manufacturers Oral Proteins and Peptides Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Oral Proteins and Peptides Market Size by Type
4.1 Global Oral Proteins and Peptides Historic Market Review by Type (2016-2021)
4.1.1 Global Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
4.1.2 Global Oral Proteins and Peptides Revenue Market Share by Type (2016-2021)
4.1.3 Global Oral Proteins and Peptides Price by Type (2016-2021)
4.2 Global Oral Proteins and Peptides Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Oral Proteins and Peptides Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Proteins and Peptides Revenue Forecast by Type (2022-2027)
4.2.3 Global Oral Proteins and Peptides Price Forecast by Type (2022-2027)
5 Global Oral Proteins and Peptides Market Size by Application
5.1 Global Oral Proteins and Peptides Historic Market Review by Application (2016-2021)
5.1.1 Global Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
5.1.2 Global Oral Proteins and Peptides Revenue Market Share by Application (2016-2021)
5.1.3 Global Oral Proteins and Peptides Price by Application (2016-2021)
5.2 Global Oral Proteins and Peptides Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Oral Proteins and Peptides Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Proteins and Peptides Revenue Forecast by Application (2022-2027)
5.2.3 Global Oral Proteins and Peptides Price Forecast by Application (2022-2027)
6 North America Oral Proteins and Peptides Market Facts & Figures
6.1 North America Oral Proteins and Peptides Sales by Company
6.1.1 North America Oral Proteins and Peptides Sales by Company (2016-2021)
6.1.2 North America Oral Proteins and Peptides Revenue by Company (2016-2021)
6.2 North America Oral Proteins and Peptides Sales Breakdown by Type
6.2.1 North America Oral Proteins and Peptides Sales Breakdown by Type (2016-2021)
6.2.2 North America Oral Proteins and Peptides Sales Breakdown by Type (2022-2027)
6.3 North America Oral Proteins and Peptides Sales Breakdown by Application
6.3.1 North America Oral Proteins and Peptides Sales Breakdown by Application (2016-2021)
6.3.2 North America Oral Proteins and Peptides Sales Breakdown by Application (2022-2027)
7 Europe Oral Proteins and Peptides Market Facts & Figures
7.1 Europe Oral Proteins and Peptides Sales by Company
7.1.1 Europe Oral Proteins and Peptides Sales by Company (2016-2021)
7.1.2 Europe Oral Proteins and Peptides Revenue by Company (2016-2021)
7.2 Europe Oral Proteins and Peptides Sales Breakdown by Type
7.2.1 Europe Oral Proteins and Peptides Sales Breakdown by Type (2016-2021)
7.2.2 Europe Oral Proteins and Peptides Sales Breakdown by Type (2022-2027)
7.3 Europe Oral Proteins and Peptides Sales Breakdown by Application
7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)
8 China Oral Proteins and Peptides Market Facts & Figures
8.1 China Oral Proteins and Peptides Sales by Company
8.1.1 China Oral Proteins and Peptides Sales by Company (2016-2021)
8.1.2 China Oral Proteins and Peptides Revenue by Company (2016-2021)
8.2 China Oral Proteins and Peptides Sales Breakdown by Type
8.2.1 China Oral Proteins and Peptides Sales Breakdown by Type (2016-2021)
8.2.2 China Oral Proteins and Peptides Sales Breakdown by Type (2022-2027)
8.3 China Oral Proteins and Peptides Sales Breakdown by Application
8.3.1 China 154 Sales Breakdown by Application (2016-2021)
8.3.2 China 154 Sales Breakdown by Application (2022-2027)
9 Japan Oral Proteins and Peptides Market Facts & Figures
9.1 Japan Oral Proteins and Peptides Sales by Company
9.1.1 Japan Oral Proteins and Peptides Sales by Company (2016-2021)
9.1.2 Japan Oral Proteins and Peptides Revenue by Company (2016-2021)
9.2 Japan Oral Proteins and Peptides Sales Breakdown by Type
9.2.1 Japan Oral Proteins and Peptides Sales Breakdown by Type (2016-2021)
9.2.2 Japan Oral Proteins and Peptides Sales Breakdown by Type (2022-2027)
9.3 Japan Oral Proteins and Peptides Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Oral Proteins and Peptides Market Facts & Figures
10.1 Southeast Asia Oral Proteins and Peptides Sales by Company
10.1.1 Southeast Asia Oral Proteins and Peptides Sales by Company (2016-2021)
10.1.2 Southeast Asia Oral Proteins and Peptides Revenue by Company (2016-2021)
10.2 Southeast Asia Oral Proteins and Peptides Sales Breakdown by Type
10.2.1 Southeast Asia Oral Proteins and Peptides Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Oral Proteins and Peptides Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Oral Proteins and Peptides Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Oral Proteins and Peptides Market Facts & Figures
11.1 India Oral Proteins and Peptides Sales by Company
11.1.1 India Oral Proteins and Peptides Sales by Company (2016-2021)
11.1.2 India Oral Proteins and Peptides Revenue by Company (2016-2021)
11.2 India Oral Proteins and Peptides Sales Breakdown by Type
11.2.1 India Oral Proteins and Peptides Sales Breakdown by Type (2016-2021)
11.2.2 India Oral Proteins and Peptides Sales Breakdown by Type (2022-2027)
11.3 India Oral Proteins and Peptides Sales Breakdown by Application
11.3.1 India Oral Proteins and Peptides Sales Breakdown by Application (2016-2021)
11.3.2 India Oral Proteins and Peptides Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Oral Proteins and Peptides Business
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Business Overview
12.1.3 Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Oral Proteins and Peptides Products Offered
12.1.5 Allergan Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Oral Proteins and Peptides Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Biocon
12.3.1 Biocon Corporation Information
12.3.2 Biocon Business Overview
12.3.3 Biocon Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biocon Oral Proteins and Peptides Products Offered
12.3.5 Biocon Recent Development
12.4 Generex Biotechnology
12.4.1 Generex Biotechnology Corporation Information
12.4.2 Generex Biotechnology Business Overview
12.4.3 Generex Biotechnology Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Generex Biotechnology Oral Proteins and Peptides Products Offered
12.4.5 Generex Biotechnology Recent Development
12.5 Novo Nordisk
12.5.1 Novo Nordisk Corporation Information
12.5.2 Novo Nordisk Business Overview
12.5.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novo Nordisk Oral Proteins and Peptides Products Offered
12.5.5 Novo Nordisk Recent Development
12.6 Synergy Pharmaceuticals
12.6.1 Synergy Pharmaceuticals Corporation Information
12.6.2 Synergy Pharmaceuticals Business Overview
12.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Synergy Pharmaceuticals Oral Proteins and Peptides Products Offered
12.6.5 Synergy Pharmaceuticals Recent Development
12.7 Tarsa Therapeutics
12.7.1 Tarsa Therapeutics Corporation Information
12.7.2 Tarsa Therapeutics Business Overview
12.7.3 Tarsa Therapeutics Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Tarsa Therapeutics Oral Proteins and Peptides Products Offered
12.7.5 Tarsa Therapeutics Recent Development
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Business Overview
12.8.3 Sanofi Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sanofi Oral Proteins and Peptides Products Offered
12.8.5 Sanofi Recent Development
12.9 Hoffmann-La Roche
12.9.1 Hoffmann-La Roche Corporation Information
12.9.2 Hoffmann-La Roche Business Overview
12.9.3 Hoffmann-La Roche Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hoffmann-La Roche Oral Proteins and Peptides Products Offered
12.9.5 Hoffmann-La Roche Recent Development
12.10 Synthetic Biologics
12.10.1 Synthetic Biologics Corporation Information
12.10.2 Synthetic Biologics Business Overview
12.10.3 Synthetic Biologics Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Synthetic Biologics Oral Proteins and Peptides Products Offered
12.10.5 Synthetic Biologics Recent Development
12.11 Hovione
12.11.1 Hovione Corporation Information
12.11.2 Hovione Business Overview
12.11.3 Hovione Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hovione Oral Proteins and Peptides Products Offered
12.11.5 Hovione Recent Development
12.12 Novartis
12.12.1 Novartis Corporation Information
12.12.2 Novartis Business Overview
12.12.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Novartis Oral Proteins and Peptides Products Offered
12.12.5 Novartis Recent Development
13 Oral Proteins and Peptides Manufacturing Cost Analysis
13.1 Oral Proteins and Peptides Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oral Proteins and Peptides
13.4 Oral Proteins and Peptides Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oral Proteins and Peptides Distributors List
14.3 Oral Proteins and Peptides Customers
15 Market Dynamics
15.1 Oral Proteins and Peptides Market Trends
15.2 Oral Proteins and Peptides Drivers
15.3 Oral Proteins and Peptides Market Challenges
15.4 Oral Proteins and Peptides Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Oral Proteins and Peptides Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Oral Proteins and Peptides Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Oral Proteins and Peptides Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Oral Proteins and Peptides Sales (K MT) by Region (2016-2021)
Table 5. Global Oral Proteins and Peptides Sales Market Share by Region (2016-2021)
Table 6. Global Oral Proteins and Peptides Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Oral Proteins and Peptides Revenue Share by Region (2016-2021)
Table 8. Global Oral Proteins and Peptides Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Oral Proteins and Peptides Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Oral Proteins and Peptides Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Oral Proteins and Peptides Revenue Share Forecast by Region (2022-2027)
Table 12. Global Oral Proteins and Peptides Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Oral Proteins and Peptides Sales Share by Company (2016-2021)
Table 14. Global Oral Proteins and Peptides Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Oral Proteins and Peptides Revenue Share by Company (2016-2021)
Table 16. Global Oral Proteins and Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Proteins and Peptides as of 2020)
Table 17. Global Oral Proteins and Peptides Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Oral Proteins and Peptides Manufacturing Sites and Area Served
Table 19. Manufacturers Oral Proteins and Peptides Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Oral Proteins and Peptides Sales (K MT) by Type (2016-2021)
Table 22. Global Oral Proteins and Peptides Sales Share by Type (2016-2021)
Table 23. Global Oral Proteins and Peptides Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Oral Proteins and Peptides Price (USD/MT) by Type (2016-2021)
Table 25. Global Oral Proteins and Peptides Sales Share by Type (2022-2027)
Table 26. Global Oral Proteins and Peptides Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Oral Proteins and Peptides Revenue Share by Type (2022-2027)
Table 28. Global Oral Proteins and Peptides Price (USD/MT) by Type (2022-2027)
Table 29. Global Oral Proteins and Peptides Sales (K MT) by Application (2016-2021)
Table 30. Global Oral Proteins and Peptides Sales Share by Application (2016-2021)
Table 31. Global Oral Proteins and Peptides Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Oral Proteins and Peptides Price (USD/MT) by Application (2016-2021)
Table 33. Global Oral Proteins and Peptides Sales (K MT) by Application (2022-2027)
Table 34. Global Oral Proteins and Peptides Sales Share by Application (2022-2027)
Table 35. Global Oral Proteins and Peptides Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Oral Proteins and Peptides Revenue Share by Application (2022-2027)
Table 37. Global Oral Proteins and Peptides Price (USD/MT) by Application (2022-2027)
Table 38. North America Oral Proteins and Peptides Sales (K MT) by Company (2016-2021)
Table 39. North America Oral Proteins and Peptides Sales Market Share by Company (2016-2021)
Table 40. North America Oral Proteins and Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Oral Proteins and Peptides Revenue Market Share by Company (2016-2021)
Table 42. North America Oral Proteins and Peptides Sales by Type (2016-2021) & (K MT)
Table 43. North America Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
Table 44. North America Oral Proteins and Peptides Sales by Type (2022-2027) & (K MT)
Table 45. North America Oral Proteins and Peptides Sales Market Share by Type (2022-2027)
Table 46. North America Oral Proteins and Peptides Sales by Application (2016-2021) & (K MT)
Table 47. North America Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
Table 48. North America Oral Proteins and Peptides Sales by Application (2022-2027) & (K MT)
Table 49. North America Oral Proteins and Peptides Sales Market Share by Application (2022-2027)
Table 50. Europe Oral Proteins and Peptides Sales (K MT) by Company (2016-2021)
Table 51. Europe Oral Proteins and Peptides Sales Market Share by Company (2016-2021)
Table 52. Europe Oral Proteins and Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Oral Proteins and Peptides Revenue Market Share by Company (2016-2021)
Table 54. Europe Oral Proteins and Peptides Sales by Type (2016-2021) & (K MT)
Table 55. Europe Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
Table 56. Europe Oral Proteins and Peptides Sales by Type (2022-2027) & (K MT)
Table 57. Europe Oral Proteins and Peptides Sales Market Share by Type (2022-2027)
Table 58. Europe Oral Proteins and Peptides Sales by Application (2016-2021) & (K MT)
Table 59. Europe Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
Table 60. Europe Oral Proteins and Peptides Sales by Application (2022-2027) & (K MT)
Table 61. Europe Oral Proteins and Peptides Sales Market Share by Application (2022-2027)
Table 62. China Oral Proteins and Peptides Sales (K MT) by Company (2016-2021)
Table 63. China Oral Proteins and Peptides Sales Market Share by Company (2016-2021)
Table 64. China Oral Proteins and Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Oral Proteins and Peptides Revenue Market Share by Company (2016-2021)
Table 66. China Oral Proteins and Peptides Sales by Type (2016-2021) & (K MT)
Table 67. China Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
Table 68. China Oral Proteins and Peptides Sales by Type (2022-2027) & (K MT)
Table 69. China Oral Proteins and Peptides Sales Market Share by Type (2022-2027)
Table 70. China Oral Proteins and Peptides Sales by Application (2016-2021) & (K MT)
Table 71. China Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
Table 72. China Oral Proteins and Peptides Sales by Application (2022-2027) & (K MT)
Table 73. China Oral Proteins and Peptides Sales Market Share by Application (2022-2027)
Table 74. Japan Oral Proteins and Peptides Sales (K MT) by Company (2016-2021)
Table 75. Japan Oral Proteins and Peptides Sales Market Share by Company (2016-2021)
Table 76. Japan Oral Proteins and Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Oral Proteins and Peptides Revenue Market Share by Company (2016-2021)
Table 78. Japan Oral Proteins and Peptides Sales by Type (2016-2021) & (K MT)
Table 79. Japan Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
Table 80. Japan Oral Proteins and Peptides Sales by Type (2022-2027) & (K MT)
Table 81. Japan Oral Proteins and Peptides Sales Market Share by Type (2022-2027)
Table 82. Japan Oral Proteins and Peptides Sales by Application (2016-2021) & (K MT)
Table 83. Japan Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
Table 84. Japan Oral Proteins and Peptides Sales by Application (2022-2027) & (K MT)
Table 85. Japan Oral Proteins and Peptides Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Oral Proteins and Peptides Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Oral Proteins and Peptides Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Oral Proteins and Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Oral Proteins and Peptides Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Oral Proteins and Peptides Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Oral Proteins and Peptides Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Oral Proteins and Peptides Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Oral Proteins and Peptides Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Oral Proteins and Peptides Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Oral Proteins and Peptides Sales Market Share by Application (2022-2027)
Table 98. India Oral Proteins and Peptides Sales (K MT) by Company (2016-2021)
Table 99. India Oral Proteins and Peptides Sales Market Share by Company (2016-2021)
Table 100. India Oral Proteins and Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Oral Proteins and Peptides Revenue Market Share by Company (2016-2021)
Table 102. India Oral Proteins and Peptides Sales by Type (2016-2021) & (K MT)
Table 103. India Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
Table 104. India Oral Proteins and Peptides Sales by Type (2022-2027) & (K MT)
Table 105. India Oral Proteins and Peptides Sales Market Share by Type (2022-2027)
Table 106. India Oral Proteins and Peptides Sales by Application (2016-2021) & (K MT)
Table 107. India Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
Table 108. India Oral Proteins and Peptides Sales by Application (2022-2027) & (K MT)
Table 109. India Oral Proteins and Peptides Sales Market Share by Application (2022-2027)
Table 110. Allergan Corporation Information
Table 111. Allergan Description and Business Overview
Table 112. Allergan Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Allergan Oral Proteins and Peptides Product
Table 114. Allergan Recent Development
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. AstraZeneca Oral Proteins and Peptides Product
Table 119. AstraZeneca Recent Development
Table 120. Biocon Corporation Information
Table 121. Biocon Description and Business Overview
Table 122. Biocon Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Biocon Oral Proteins and Peptides Product
Table 124. Biocon Recent Development
Table 125. Generex Biotechnology Corporation Information
Table 126. Generex Biotechnology Description and Business Overview
Table 127. Generex Biotechnology Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Generex Biotechnology Oral Proteins and Peptides Product
Table 129. Generex Biotechnology Recent Development
Table 130. Novo Nordisk Corporation Information
Table 131. Novo Nordisk Description and Business Overview
Table 132. Novo Nordisk Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Novo Nordisk Oral Proteins and Peptides Product
Table 134. Novo Nordisk Recent Development
Table 135. Synergy Pharmaceuticals Corporation Information
Table 136. Synergy Pharmaceuticals Description and Business Overview
Table 137. Synergy Pharmaceuticals Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Synergy Pharmaceuticals Oral Proteins and Peptides Product
Table 139. Synergy Pharmaceuticals Recent Development
Table 140. Tarsa Therapeutics Corporation Information
Table 141. Tarsa Therapeutics Description and Business Overview
Table 142. Tarsa Therapeutics Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Tarsa Therapeutics Oral Proteins and Peptides Product
Table 144. Tarsa Therapeutics Recent Development
Table 145. Sanofi Corporation Information
Table 146. Sanofi Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Sanofi Description and Business Overview
Table 148. Sanofi Oral Proteins and Peptides Product
Table 149. Sanofi Recent Development
Table 150. Hoffmann-La Roche Corporation Information
Table 151. Hoffmann-La Roche Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Hoffmann-La Roche Description and Business Overview
Table 153. Hoffmann-La Roche Oral Proteins and Peptides Product
Table 154. Hoffmann-La Roche Recent Development
Table 155. Synthetic Biologics Corporation Information
Table 156. Synthetic Biologics Description and Business Overview
Table 157. Synthetic Biologics Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Synthetic Biologics Oral Proteins and Peptides Product
Table 159. Synthetic Biologics Recent Development
Table 160. Hovione Corporation Information
Table 161. Hovione Description and Business Overview
Table 162. Hovione Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Hovione Oral Proteins and Peptides Product
Table 164. Hovione Recent Development
Table 165. Novartis Corporation Information
Table 166. Novartis Description and Business Overview
Table 167. Novartis Oral Proteins and Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Novartis Oral Proteins and Peptides Product
Table 169. Novartis Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Oral Proteins and Peptides Distributors List
Table 173. Oral Proteins and Peptides Customers List
Table 174. Oral Proteins and Peptides Market Trends
Table 175. Oral Proteins and Peptides Market Drivers
Table 176. Oral Proteins and Peptides Market Challenges
Table 177. Oral Proteins and Peptides Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Proteins and Peptides Product Picture
Figure 2. Global Oral Proteins and Peptides Sales Market Share by Type in 2021 & 2027
Figure 3. Linaclotide Product Picture
Figure 4. Calcitonin Product Picture
Figure 5. Insulin Product Picture
Figure 6. Octreotide Product Picture
Figure 7. Global Oral Proteins and Peptides Sales Market Share by Application in 2021 & 2027
Figure 8. Gastric & Digestive Disorders Examples
Figure 9. Bone Diseases Examples
Figure 10. Diabetes Examples
Figure 11. Hormonal Disorders Examples
Figure 12. Global Oral Proteins and Peptides Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oral Proteins and Peptides Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Oral Proteins and Peptides Sales (K MT) Growth Rate (2016-2027)
Figure 15. Global Oral Proteins and Peptides Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 16. Global Oral Proteins and Peptides Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Oral Proteins and Peptides Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Oral Proteins and Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Oral Proteins and Peptides Sales (K MT) Growth Rate (2016-2027)
Figure 20. Europe Oral Proteins and Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Oral Proteins and Peptides Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Oral Proteins and Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Oral Proteins and Peptides Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Oral Proteins and Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Oral Proteins and Peptides Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Oral Proteins and Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Oral Proteins and Peptides Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Oral Proteins and Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Oral Proteins and Peptides Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Oral Proteins and Peptides Players Market Share by Revenue in Oral Proteins and Peptides: 2016 & 2020
Figure 31. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Oral Proteins and Peptides Revenue Share by Type (2016-2021)
Figure 33. Global Oral Proteins and Peptides Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Oral Proteins and Peptides Revenue Share by Application (2016-2021)
Figure 35. Global Oral Proteins and Peptides Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Oral Proteins and Peptides Sales Market Share by Type in 2020
Figure 37. North America Oral Proteins and Peptides Sales Market
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs